A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target
- 12 December 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (52), 21052-21056
- https://doi.org/10.1073/pnas.1110534108
Abstract
Hepatitis C virus (HCV) infection is a global health burden with over 170 million people infected worldwide. In a significant portion of patients chronic hepatitis C infection leads to serious liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma. The HCV NS3 protein is essential for viral polyprotein processing and RNA replication and hence viral replication. It is composed of an N-terminal serine protease domain and a C-terminal helicase/NTPase domain. For full activity, the protease requires the NS4A protein as a cofactor. HCV NS3/4A protease is a prime target for developing direct-acting antiviral agents. First-generation NS3/4A protease inhibitors have recently been introduced into clinical practice, markedly changing HCV treatment options. To date, crystal structures of HCV NS3/4A protease inhibitors have only been reported in complex with the protease domain alone. Here, we present a unique structure of an inhibitor bound to the full-length, bifunctional protease-helicase NS3/4A and show that parts of the P4 capping and P2 moieties of the inhibitor interact with both protease and helicase residues. The structure sheds light on inhibitor binding to the more physiologically relevant form of the enzyme and supports exploring inhibitor-helicase interactions in the design of the next generation of HCV NS3/4A protease inhibitors. In addition, small angle X-ray scattering confirmed the observed protease-helicase domain assembly in solution.Keywords
This publication has 32 references indexed in Scilit:
- Visualizing ATP-Dependent RNA Translocation by the NS3 Helicase from HCVJournal of Molecular Biology, 2011
- Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor bindingProceedings of the National Academy of Sciences of the United States of America, 2010
- Flexibility between the Protease and Helicase Domains of the Dengue Virus NS3 Protein Conferred by the Linker Region and Its Functional ImplicationsJournal of Biological Chemistry, 2010
- Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 HelicasePublished by Elsevier BV ,2008
- Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complexProceedings of the National Academy of Sciences of the United States of America, 2008
- Evasion of intracellular host defence by hepatitis C virusNature, 2005
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D-Biological Crystallography, 2004
- PRIMUS: a Windows PC-based system for small-angle scattering data analysisJournal of Applied Crystallography, 2003
- CRYSOL– a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic CoordinatesJournal of Applied Crystallography, 1995
- Determination of the regularization parameter in indirect-transform methods using perceptual criteriaJournal of Applied Crystallography, 1992